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Telomere length maintenance is crucial for cells that divide many times. TIN2 is 25 an important regulator of telomere length, and mutations in TINF2, the gene encoding 26 TIN2, cause short telomere syndromes. While the genetics underscore the importance of 27 TIN2, the mechanism through which TIN2 regulates telomere length remains unclear. 28
Here, we characterize the effects of TIN2 on telomerase activity. We identified a new 29 isoform in human cells, TIN2M, that is expressed at similar levels to previously studied 30 TIN2 isoforms. Additionally, we found that all three TIN2 isoforms stimulated 31 telomerase processivity beyond the previously characterized stimulation by TPP1/POT1. 32
Mutations in the TPP1 TEL-patch abrogated this stimulation, implicating TIN2 as a 33 component of the TPP1/POT1 processivity complex. All three TIN2 isoforms localized to 34 telomeres in vivo but had distinct effects on telomere length, suggesting they are 35 functionally distinct. These data contrast previous descriptions of TIN2 a simple 36 scaffolding protein, showing that TIN2 isoforms directly regulate telomerase. 37
Importance 38
Telomere length regulation maintains the fine balance between cancer and short 39 telomere syndromes, which are complex degenerative diseases including bone marrow 40 failure and pulmonary fibrosis. The enzyme telomerase maintains telomere equilibrium 41 through highly regulated addition of telomere sequence to chromosome ends. Here, we 42 uncover a previously unknown biochemical role for human shelterin component TIN2 in 43 regulating telomerase enzyme processivity and suggest that TIN2 functions with 44
Introduction
54
Telomere length in human cells is maintained around a tight equilibrium that 55 prevents life-threatening disease. Telomere shortening leads to a characteristic set of 56 degenerative diseases, including pulmonary fibrosis, bone marrow failure, and immune 57 deficiency, collectively called short telomere syndromes(1). In contrast, 90% of human 58 cancers upregulate telomerase, and mutations that increase telomerase levels predispose 59 to cancer(2-4). While we understand many component pathways that regulate telomere 60 length, a detailed integrated mechanism of telomere length regulation is not fully 61
understood. 62
Human telomeres consist of about 10kb of TTAGGG repeats, that are mostly 63 double-stranded DNA with a single-stranded 3' overhang, all bound by a protein complex 64 termed shelterin(5). This DNA-protein complex protects chromosome ends, and shelterin 65 both positively and negatively regulates telomere repeat addition by telomerase. The 66 shelterin complex consists of six subunits: two double-stranded DNA binding proteins 67 TRF1 and TRF2(6-9), a single-stranded telomeric binding protein POT1(10, 11), as well 68 as interacting proteins TPP1, TIN2, and RAP1(12-16). 69 POT1 and TPP1 form a heterodimer that binds single stranded telomeric DNA 70 and stimulates telomerase processivity in vivo and in vitro (17) (18) (19) . This stimulation is 71 mediated though the TPP1 OB-fold, which contains conserved TEL-patch and NOB 72 regions that directly interact with the TEN domain of TERT(20-23). Mutations in the 73 TEL-patch abrogate the stimulation of processivity, and compensatory charge swap 74 mutations in TERT restore function(24), suggesting the direct binding of TPP1/POT1 75 heterodimer to TERT mediates processivity. 76 TIN2, encoded by the TINF2 gene, localizes to telomeres through interactions 77 with TRF1, TRF2, and TPP1 ( Figure 1A , B). TIN2 interaction with TPP1 is essential for 78 TPP1/POT1 localization and function in cells(25-28). TIN2 also binds to the double 79 stranded DNA binding proteins TRF1 and TRF2(12, 29). Knocking down TIN2 also 80 causes loss of TRF1 and TRF2 at telomeres, suggesting that TIN2 stabilizes TRF1 and 81 TRF2 binding to telomeres (29) . Because of its interactions with TRF1, TRF2, and 82 TPP1/POT1, TIN2 has been described as a molecular bridge between the dsDNA-and 83 ssDNA-binding shelterin components. However, it is likely that TIN2 performs 84 additional telomeric functions, as shelterin may consist of distinct functional 85 TIN2L encompasses all 354 amino acids of TIN2S with an additional 97 C-terminal 117 amino acid residues(48), including a highly conserved domain ( Figure 1B To test whether this band corresponds to an alternatively spliced TIN2 isoform, 128 we used a modified 3' RACE with PacBio sequencing to identify all full-length 129 expressed isoforms in human and mouse cells. In 293T cells, TIN2S and TIN2L cDNAs 130 were identified along with a third major isoform, which would encode the expected 131 molecular weight for the unknown protein. We termed this isoform TIN2M for TIN2 132 "medium". TIN2M results from retention of the last intron, between exons 8 and 9, that 133 encodes 13 amino acids of unique sequence ( 408 -VSGKEQKAGKGDG-420 ) before 134 reaching a stop codon ( Figure 1D -E). Sequence read counts indicated that TIN2M and 135 TIN2L mRNAs were expressed at similar levels, while TIN2S had 2-fold greater 136 representation than each of the others, suggesting it is the predominant transcript ( Figure  137 1D and Supplementary Figure 2A) . 3' RACE further showed that TIN2M was present at 138 similar levels in four other human cell lines (HeLa, K562, RPE-1, and a newly derived 139 LCL) ( Figure 1E ). In addition to these three major isoforms in human cells, we identified 140 a number of additional recurrent exon skipping, intron retention, and alternative 141 polyadenylation site usage events, including exon 2 skipping described previously(50) 142 (Supplementary Figure 2A) . We found that two different mouse strains (C57BL/6 and 143 CAST/EiJ) expressed just one TIN2 isoform that is most similar to TIN2L, as previously 144 described(48, 51) (Supplementary Figure 2B) . 145
Evidence for expression of TIN2M was also found in publicly available data from 146
PacBio IsoSeq of MCF-7 breast cancer cells (http://www.pacb.com/blog/data-release-147
human-mcf-7-transcriptome/). Additionally, genome-wide ribosome profiling data from 148 GWIPS-viz shows ribosome peaks present in the unique coding region of the TIN2M 149 retained intron(52). TIN2M and TIN2L, but not TIN2S, contain the recently identified 150 CK2 phosphorylation site(49). All three of the expressed isoforms contain the 151 documented cluster of telomere syndrome patient mutations and the other known 152 interaction domains, suggesting that any of these three isoforms could mediate the short 153 telomere phenotypes seen in vivo. 154 155 TIN2 cooperates with TPP1/POT1 to stimulate telomerase processivity 156 TIN2 interacts directly with TPP1, a processivity factor that heterodimerizes with 157 POT1 and directly binds telomerase through the TPP1 TEL-patch domain (18, (20) (21) (22) 53) . 158
To examine whether TIN2 affects telomerase activity or processivity, we adapted the 159 cell-based system overexpressing TERT, TR, POT1, and TPP1 used by Nandakumar et al 160 (20) . By co-overexpressing TERT, TR, TPP1, and POT1 in cells, cell lysates can be used 161 in direct telomerase activity assays(18-20, 54). Because endogenous telomere proteins 162 are expressed at low levels, the telomerase activity observed in this system result from 163 the overexpressed proteins. We adapted this system to generate cells constitutively 164 expressing TERT, TR, TPP1, and POT1, where TIN2 can be introduced by transient 165
transfection. 166
For reproducible overexpression of the protein components, we created a 167 polycistronic expression cassette containing FLAG-TPP1, FLAG-POT1, and FLAG-168 TERT separated by 2A peptides (Figure 2A and Supplementary Figure 3A) . As a 169 negative control, we mutated the TPP1 TEL-patch (TPP1 E169A/E171A)(20), referred to 170 here as TPP1 TEL , to test whether any effects of TIN2 are mediated through TPP1/POT1 171 stimulation of telomerase ( Figure 2A and Supplementary Figure 3B) . Then, we generated 172 a clonal cell line overexpressing TR in 293TREx FLP-in cells, into which we integrated 173 the respective expression cassette at a unique genomic locus using the FLP-in system. 174
The resulting cell lines are referred to as TPP1/POT1/TERT and TPP1 TEL /POT1/TERT 175 (Figure 2A-C) . 176
To examine the interaction of TIN2 with TPP1/POT1 and telomerase, the three 177 TIN2 isoforms were individually transfected into each cell line. Each of the three TIN2 178 isoforms reproducibly co-immunoprecipitated with TPP1/POT1 and TERT in reciprocal 179 pull downs of either myc-TIN2 or FLAG-TPP1/POT1/TERT ( Figure 2D and 180 Supplementary Figure 4) . We observed no change in co-immunoprecipitation of 181 TPP1/POT1 and TERT with TIN2 when any of the three isoforms carried one of the 182 common patient mutations, K280E ( Figure 2D ), as previously reported for the TIN2S 183 isoform(44, 55). Telomerase activity can be detected in these co-immunoprecipitations, 184
suggesting that the telomerase in complex with TIN2 is active (data not shown). We 185 conclude that all three isoforms of TIN2 are interacting with TPP1/POT1 in complex 186 with active telomerase, and the K280E patient mutation does not disrupt this interaction. 187
To examine the effects of TIN2 on telomerase activity, we transfected the myc-188 Because all three TIN2 isoforms stimulated telomerase to the same extent in a 203 TPP1/POT1 dependent manner, we tested whether patient mutations TIN2-K280E, TIN2-204 R282S, TIN2-R282H, or TIN2-K280X affect processivity. In some instances, we found 205 that TIN2 mutants were deficient at stimulating telomerase activity, but this result was 206 variable both in whole-cell lysates and in TIN2 co-immunoprecipitations (Supplementary 207 Figure 5 and data not shown). Because the mutants are dominant-negative in vivo, we 208 tried co-expressing wild-type TIN2 with a mutant TIN2, but there was no change in 209 processivity stimulation in this setting (Supplementary Figure 7) Figure 4A ). Using this system, the expression 227 constructs were integrated at a unique genomic locus, and isogenic, polyclonal cell lines 228 were selected. Western blot analysis showed similar expression levels of TIN2S, TIN2M, 229 and TIN2L that was not affected by the K280E mutation ( Figure 4A ). Using indirect 230 immunofluorescence, we found that all three isoforms, with or without the K280E patient 231 mutation, showed discrete foci that co-localized with TRF2, indicating that they each 232 localize to telomeres in vivo ( Figure 4B ). 233
Previous work has shown that overexpression of wild-type TIN2S had little effect 234 on telomere length, while overexpression of TIN2S-K280E, TIN2S-R282S, or TIN2S-235 R282H decreased telomere length(12, 44). A recent study showed overexpression of 236 TIN2L resulted in some increase in telomere length(49). Having these isoform-specific 237 polyclonal TIN2 overexpressing cell lines in hand, we examined how the TIN2 constructs 238 affect telomere length. We passaged these cells and monitored telomere length by 239
Southern blot and q-FISH analysis. TIN2S, TIN2S-K280E, and the control GFP cell lines 240 showed no significant changes in telomere length over time ( We next examined telomere aberrations in blinded q-FISH images. We saw no 251 changes in signal-free ends, PQ ratios, sister telomere heterogeneity, or telomere fusions 252 (Supplementary Figure 8) . However, we found a variable but elevated incidence of 253 telomere doublets, or fragile telomeres, which are indicative of telomere replication 254 defects, in cells overexpressing TIN2M and the mutant isoforms TIN2S-K280E, TIN2M-255 K280E, and TIN2L-K280E (Supplementary Figure 8A) . These results support the 256 conclusion that the telomere elongation is due to an effect of TIN2 on TPP1/POT1 257 function and further suggest that TIN2 participates with TPP1 and POT1 in facilitating 258 telomere replication as well as stimulating telomerase processivity. 259
Discussion
260
We have identified a new isoform of TIN2, TIN2M, and have shown that each of 261 the three TIN2 isoforms cooperate with TPP1/POT1 to stimulate telomerase processivity. 262
We found that the TIN2 isoforms play different roles in telomere length regulation in 263 cells. Our data suggest that TIN2 forms a functional shelterin subcomplex with TPP1/ 264 POT1. Considering TIN2 as part of the telomerase processivity complex provides a new 265
way to think about its role in telomere length regulation. 266
The mutations in TINF2 in short telomere syndrome patients mostly cluster in a 267 TIN2 domain of unknown function in exon 6 near the C-terminus of TIN2(34, 35). 268
Genetic evidence strongly supports a dominant negative mechanism for the mutant TIN2 269 proteins. First, TIN2 mutations have autosomal dominant inheritance. The mutant 270 proteins are stably expressed and cause telomere shortening despite the presence of a 271 wild-type TIN2. Secondly, the clustering of disease associated alleles rather than 272 distribution across the coding sequence suggests these are not simply inactivating 273 mutations but rather a gain of function. Finally, there is evidence for selection against the 274 mutant proteins in the hematopoietic lineage in vivo(37). The dominant negative 275 mechanism is also supported by experimental evidence(45), but the molecular nature of 276 this effect is not well understood. 277
TIN2 C-terminus plays an essential role in telomere length regulation 278
We found that all three TIN2 isoforms form a complex with TPP1/POT1, 279 stimulate telomerase processivity, and localize to telomeres, yet have different effects on 280 telomere length in cells, underscoring the important role of the TIN2 C-terminus. TIN2 281 can be divided into two regions: the shelterin-interacting region in the N-terminus, and 282 the C-terminal region that includes the patient mutation cluster, the variable C-terminal 283 extensions of TIN2M and TIN2L, and several other interaction sites and 284 modifications(47, 49, 57, 58) ( Figure 1B ). All three isoforms contain the shelterin-285 interacting domain and patient mutation cluster, varying only in the C-terminal extension 286 after E354. 287
The structure is known for much of the shelterin-interacting region, including the 288 N-terminal TRF2/TPP1 binding domain (TIN2 1-202 )(59) and the short TRF1-interacting 289 motif (TIN2 256-276 )(60). There is no structural information, however, for the C-terminal 290 region, including both the mutation hotspot and the variable C-terminal extension, which 291 contains a highly conserved region with a CK2 phosphorylation site at S396(49). ). TIN2 could enhance telomerase processivity by improving the TPP1/POT1 complex 308 stability or its interaction with telomerase, or by promoting the telomeric ssDNA 309 interaction of the complex, or some combination of these ( Figure 5A ). 310
Interestingly, the identification of TIN2 as an additional component to an already 311 known processivity factor is reminiscent of recent findings in Tetrahymena. The 312
Tetrahymena telomerase holoenzyme structure(61) revealed previously unknown 313 subunits, Teb2 and Teb3, that interact with the previously defined Teb1-p50 processivity 314
complex. The addition of these proteins to in vitro reactions further stimulated telomerase 315 processivity, possibly by stabilizing the complete, assembled, processive enzyme 316 complex(62). Further, this structure revealed that the telomerase holoenzyme contains 317 two single-stranded DNA binding complexes: the p50/TEB processivity factor, which 318 stimulates telomeric G-strand synthesis by telomerase, and the CST complex, which 319 stimulates telomeric C-strand synthesis by lagging strand replication machinery. This is 320 the first evidence of physical coupling of two telomere maintenance processes that have 321 long been known to be coupled in vivo (reviewed in(63)). 322
Our results with TIN2 parallel the discovery of the missing components of the 323 TEB processivity complex in Tetrahymena(61, 62), suggesting that TIN2 binding to 324 TPP1/POT1 stabilizes the complex and thus promotes processivity. Interestingly, CST 325 (CTC1/STN1/TEN1), a second ssDNA telomeric complex, interacts with TPP1/POT1 to 326 limit telomere extension by coupling C-strand to G-strand synthesis(64, 65). The C-327 terminal region of TIN2 is a candidate for coupling TIN2/TPP1/POT1 with CST for 328 coordinated C-and G-strand synthesis, affecting both positive and negative telomere 329 The interpretation of TIN2/TPP1/POT1 as a ssDNA binding shelterin subcomplex 370
provides an updated view of TIN2's role in telomere length regulation. We found that 371 TIN2 is expressed as multiple isoforms that have different effects on telomere length in 372 human cells. Strikingly, we found that TIN2 is a previously unappreciated component of 373 the telomerase processivity complex. All three isoforms stimulated telomerase 374 processivity in a TPP1/POT1 dependent manner. Further biochemical work on this 375 heterotrimeric ssDNA telomere binding protein will elucidate the mechanism of TIN2 376 regulation of telomere length and how it is disrupted in short telomere syndromes. isoforms. Sequences were uploaded to PRALINE multiple sequence alignment using the 654 default parameters(73, 74). To make the sequence conservation heat map, PRALINE 655 output was imported into Microsoft Excel, and the alignment scores (0-10) of human 656 TIN2 were colored from white=0, not conserved to navy=8-10, highly conserved. 657
Sequences used are listed in Supplementary Table 1 . 658
CRISPR editing 659
Guide RNAs were selected using the Zhang Lab CRISPR design tool 660 (http://crispr.mit.edu/). For endogenous tagging of TIN2, the guide 661 cgccaccaggggcgtagccaTGG was cloned into pX459-U6-Chimeric_BB-CBh-hSpCas9-662 2A-Puro. The repair template was generated by PCR from the cloned myc-TINF2 663 construct (Supplementary Figure 1) . 1μg of Cas9-2A-Puro+TIN2 guide was transfected 664 into 293T cells with 10 molar equivalents of the repair template using XtremeGENE9 665 (Roche, 6365787001). Editing was enriched with puromycin, cloned by limiting dilution, 666 and screened by PCR and restriction digest. Positive clones were examined by western 667 blot. While we found many edited clones, 293T cells are hypotriploid with an unstable 668 karyotype, and we observed high endogenous Myc expression that interfered with 669 western blotting for myc-tagged TIN2 (Supplementary Figure 1) . These caveats make it 670 difficult to further study TIN2 in these knock-in cell lines. 671
3'RACE and PacBio
672
The 3'RACE and sequencing was performed using samples from five human cell 673 Mean processivity values from 3 independent telomerase assays at the 40 minute 824 timepoint using the 15+ processivity method (see Methods). Orange bars are from a cell 825 line overexpressing TERT/TR but not TPP1/POT1 (Supplementary Figure 6) 
